Kewaunee Scientific (NASDAQ:KEQU) Releases Quarterly Earnings Results

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) released its quarterly earnings results on Wednesday. The technology company reported $1.09 EPS for the quarter, Zacks reports. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Kewaunee Scientific Price Performance

Shares of KEQU stock traded up $2.02 during trading hours on Wednesday, reaching $49.20. 26,237 shares of the company were exchanged, compared to its average volume of 25,215. Kewaunee Scientific has a fifty-two week low of $29.95 and a fifty-two week high of $71.33. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The stock's fifty day moving average is $59.42 and its two-hundred day moving average is $47.95. The company has a market cap of $141.30 million, a price-to-earnings ratio of 7.80 and a beta of 0.71.

Insider Buying and Selling

In other Kewaunee Scientific news, VP Elizabeth D. Phillips sold 1,850 shares of the business's stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the sale, the vice president now directly owns 13,591 shares of the company's stock, valued at approximately $736,224.47. The trade was a 11.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Thomas David Hull III sold 2,000 shares of the company's stock in a transaction dated Thursday, December 26th. The shares were sold at an average price of $63.01, for a total transaction of $126,020.00. Following the transaction, the chief executive officer now owns 42,497 shares in the company, valued at approximately $2,677,735.97. The trade was a 4.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,994 shares of company stock worth $729,430 in the last quarter. Insiders own 14.20% of the company's stock.

Institutional Trading of Kewaunee Scientific

A hedge fund recently raised its stake in Kewaunee Scientific stock. Bank of America Corp DE lifted its stake in Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) by 2,605.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 460 shares of the technology company's stock after purchasing an additional 443 shares during the period. Bank of America Corp DE's holdings in Kewaunee Scientific were worth $28,000 at the end of the most recent quarter. 32.69% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Wednesday, December 18th.

Remove Ads

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.